| Nicolette Estrada, OD | |
|
4905 San Timoteo Ave Nw, Albuquerque, NM 87114-3814 | |
| (505) 400-5319 | |
| Not Available |
| Full Name | Nicolette Estrada |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 8 Years |
| Location | 4905 San Timoteo Ave Nw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033587514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 686 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albuquerque Associates Of Optometry | 9335138452 | 6 |
News Archive
Patients undergoing colorectal operations who participated in an enhanced recovery program left the hospital sooner and had significantly lower hospital costs than patients who had the traditional approach to their care, according to a new study, which also found further postoperative improvements after adding an infection prevention protocol.
The Moderna SARS-CoV-2 vaccine was widely distributed and had a reported efficacy in clinical trials of 94.1% against the wildtype SARS-CoV-2 following the second dose administration. Therefore, Chemaitelly et al. used this as an opportunity to measure the vaccine's efficacy against these variants as reported in a recent Nature Medicine paper, finding that the vaccine has good efficacy in all aspects.
Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into an agreement with Amdipharm for the licensing and commercialization of its proprietary products throughout Asia. Under this agreement, Invida will leverage its full suite of capabilities to bring Amdipharm's products to market, from regulatory approval and licensing, through packaging and supply chain optimization, to commercialization, sales, and marketing.
Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).
A new study by American Cancer Society researchers finds medical financial hardship is very common among people in the United States, with more than half reporting problems with affordability, stress, or delaying care because of cost.
› Verified 8 days ago
| Provider Name | Albuquerque Associates Of Optometry |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114058005 PECOS PAC ID: 9335138452 Enrollment ID: O20040512000299 |
News Archive
Patients undergoing colorectal operations who participated in an enhanced recovery program left the hospital sooner and had significantly lower hospital costs than patients who had the traditional approach to their care, according to a new study, which also found further postoperative improvements after adding an infection prevention protocol.
The Moderna SARS-CoV-2 vaccine was widely distributed and had a reported efficacy in clinical trials of 94.1% against the wildtype SARS-CoV-2 following the second dose administration. Therefore, Chemaitelly et al. used this as an opportunity to measure the vaccine's efficacy against these variants as reported in a recent Nature Medicine paper, finding that the vaccine has good efficacy in all aspects.
Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into an agreement with Amdipharm for the licensing and commercialization of its proprietary products throughout Asia. Under this agreement, Invida will leverage its full suite of capabilities to bring Amdipharm's products to market, from regulatory approval and licensing, through packaging and supply chain optimization, to commercialization, sales, and marketing.
Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).
A new study by American Cancer Society researchers finds medical financial hardship is very common among people in the United States, with more than half reporting problems with affordability, stress, or delaying care because of cost.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicolette Estrada, OD 4905 San Timoteo Ave Nw, Albuquerque, NM 87114-3814 Ph: () - | Nicolette Estrada, OD 4905 San Timoteo Ave Nw, Albuquerque, NM 87114-3814 Ph: (505) 400-5319 |
News Archive
Patients undergoing colorectal operations who participated in an enhanced recovery program left the hospital sooner and had significantly lower hospital costs than patients who had the traditional approach to their care, according to a new study, which also found further postoperative improvements after adding an infection prevention protocol.
The Moderna SARS-CoV-2 vaccine was widely distributed and had a reported efficacy in clinical trials of 94.1% against the wildtype SARS-CoV-2 following the second dose administration. Therefore, Chemaitelly et al. used this as an opportunity to measure the vaccine's efficacy against these variants as reported in a recent Nature Medicine paper, finding that the vaccine has good efficacy in all aspects.
Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into an agreement with Amdipharm for the licensing and commercialization of its proprietary products throughout Asia. Under this agreement, Invida will leverage its full suite of capabilities to bring Amdipharm's products to market, from regulatory approval and licensing, through packaging and supply chain optimization, to commercialization, sales, and marketing.
Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).
A new study by American Cancer Society researchers finds medical financial hardship is very common among people in the United States, with more than half reporting problems with affordability, stress, or delaying care because of cost.
› Verified 8 days ago
R Torres O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1421 N Renaissance Blvd Ne, Suite A, Albuquerque, NM 87107 Phone: 505-342-1111 Fax: 505-342-1121 | |
Dr. Fritz Alfred Rohrkaste, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2630 Carlisle Blvd, Ne, Albuquerque, NM 87110 Phone: 505-889-3339 Fax: 505-881-0351 | |
Dr. Christopher Charles Cordes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 801 Vassar Dr Ne, Albuquerque, NM 87106 Phone: 505-248-4003 Fax: 505-248-7721 | |
Zoe Baker, OD Optometrist Medicare: Medicare Enrolled Practice Location: 6401 Holly Ave Ne, Albuquerque, NM 87113 Phone: 505-355-2020 | |
James Etre, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5150 Journal Center Blvd Ne, Albuquerque, NM 87109 Phone: 505-262-3937 Fax: 505-262-3366 | |
Hero Vision Of West Albuquerque Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4208 Central Ave Sw Ste G, Albuquerque, NM 87105 Phone: 719-576-1850 |